Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-8.83%
operating margin TTM
-7.5%
revenue TTM
128.77 Million
revenue per share TTM
0.85$
valuation ratios | |
|---|---|
| pe ratio | -23.40 |
| peg ratio | -0.46 |
| price to book ratio | -9.44 |
| price to sales ratio | 2.06 |
| enterprise value multiple | -29.12 |
| price fair value | -9.44 |
profitability ratios | |
|---|---|
| gross profit margin | 68.71% |
| operating profit margin | -7.5% |
| pretax profit margin | -8.83% |
| net profit margin | -8.83% |
| return on assets | -5.82% |
| return on equity | 37.37% |
| return on capital employed | -8.14% |
liquidity ratio | |
|---|---|
| current ratio | 2.29 |
| quick ratio | 1.70 |
| cash ratio | 0.28 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 403.35 |
| operating cycle | 590.62 |
| days of payables outstanding | 88.84 |
| cash conversion cycle | 501.78 |
| receivables turnover | 1.95 |
| payables turnover | 4.11 |
| inventory turnover | 0.90 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.76 |
| debt equity ratio | -5.28 |
| long term debt to capitalization | 1.24 |
| total debt to capitalization | 1.23 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -0.13 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.16 |
| cash per share | 0.39 |
| operating cash flow per share | -0.15 |
| free cash flow operating cash flow ratio | 1.08 |
| cash flow coverage ratios | -0.13 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -13.21 |
Frequently Asked Questions
When was the last time Heron Therapeutics, Inc. (NASDAQ:HRTX) reported earnings?
Heron Therapeutics, Inc. (HRTX) published its most recent earnings results on 12-11-2024.
What is Heron Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Heron Therapeutics, Inc. (NASDAQ:HRTX)'s trailing twelve months ROE is 37.37%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Heron Therapeutics, Inc. (HRTX) currently has a ROA of -5.82%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did HRTX's net profit margin stand at?
HRTX reported a profit margin of -8.83% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is HRTX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.29 in the most recent quarter. The quick ratio stood at 1.70, with a Debt/Eq ratio of -5.28.